Vertenoeil, G., HAFRAOUI, K., Collins, P., Somja, J., Lambert, F., De Worm, S., & Beguin, Y. (2025). Whipple's Disease Presenting with Bone Marrow Findings Mimicking Prefibrotic Myelofibrosis: A Diagnostic Pitfall. International Journal of Infectious Diseases, 108271. doi:10.1016/j.ijid.2025.108271 |
Milosevic, T. V., VERTENOEIL, G.* , Vainchenker, W., Tulkens, P. M., Constantinescu, S. N., & Van Bambeke, F. (2024). Oxazolidinone antibiotics impair ex vivo megakaryocyte differentiation from hematopoietic progenitor cells and their maturation into platelets. Antimicrobial Agents and Chemotherapy, 68, 0053324. doi:10.1128/aac.00533-24 * These authors have contributed equally to this work. |
Pirotte, M., De Voeght, A., VERTENOEIL, G., Vasbien Myriam, Paridaens, H., Somja, J., Collins, P., & Lambert, F. (December 2023). VACUOLES, E1 ENZYME, X-LINKED, AUTOINFLAMMATORY, SOMATIC SYNDROME (VEXAS SYNDROME) WITH MULTIPLE THROMBOEMBOLISM EVENTS: A BELGIAN CASE REPORT. Belgian Journal of Hematology, 14 (8), 336–42. |
Papadopoulos, N., Nédélec, A., Derenne, A., Şulea, T. A., Pecquet, C., Chachoua, I., Vertenoeil, G., Tilmant, T., Petrescu, A.-J., Mazzucchelli, G., Iorga, B. I., Vertommen, D., & Constantinescu, S. N. (05 April 2023). Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation. Nature Communications, 14 (1), 1881. doi:10.1038/s41467-023-37277-3 |
Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837 * These authors have contributed equally to this work. |
Pecquet, C., Papadopoulos, N., Balligand, T., Chachoua, I., Tisserand, A., Vertenoeil, G., Nédélec, A., Vertommen, D., Roy, A., Marty, C., Nivarthi, H., Defour, J.-P., El-Khoury, M., Hug, E., Majoros, A., Xu, E., Zagrijtschuk, O., Fertig, T. E., Marta, D. S., ... Constantinescu, S. N. (2022). Secreted Mutant Calreticulins As Rogue Cytokines in Myeloproliferative Neoplasms. Blood. doi:10.1182/blood.2022016846 |
Mosca, M.* , Hermange, G.* , Tisserand, A.* , Noble, R.* , Marzac, C., Marty, C., Le Sueur, C., Campario, H., VERTENOEIL, G., El-Khoury, M., Catelain, C., Rameau, P., Gella, C., Lenglet, J., Casadevall, N., Favier, R., Solary, E., Cassinat, B., Kiladjian, J.-J., ... Plo, I. (02 December 2021). Inferring the dynamic of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms. Blood, 138, 2231-2243. * These authors have contributed equally to this work. |
El-Khoury, M., Cabagnols, X., Mosca, M., VERTENOEIL, G., Marzac, C., Favale, F., Bluteau, O., Constantinescu, S., Raslova, H., Vainchenker, W., & Plo, I. (2020). Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms. Oncogene. doi:10.1038/s41388-020-1368-3 |
Milosevic, T. V., VERTENOEIL, G., Payen, V. L., Sonveaux, P., Tulkens, P. M., Constantinescu, S. N., & Van Bambeke, F. (2019). Prolonged inhibition and incomplete recovery of mitochondrial function in oxazolidinone-treated megakaryoblastic cell lines. International Journal of Antimicrobial Agents, 54 (5), 661-667. doi:10.1016/j.ijantimicag.2019.07.021 |
Pecquet, C., Chachoua, I., Roy, A., Balligand, T., VERTENOEIL, G., Leroy, E., Albu, R.-I., Defour, J.-P., Nivarthi, H., Hug, E., Xu, E., Ould-Amer, Y., Mouton, C., Colau, D., Vertommen, D., Shwe, M. M., Marty, C., Plo, I., Vainchenker, W., ... Constantinescu, S. N. (2019). Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants. Blood, 133 (25), 2669-2681. doi:10.1182/blood-2018-09-874578 |
Grégoire, C., GUIOT, J., Vertenoeil, G., WILLEMS, E., HAFRAOUI, K., CORHAY, J.-L., LOUIS, R., & BEGUIN, Y. (February 2016). Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma. Acta Clinica Belgica, 71, 428-430. doi:10.1080/17843286.2015.1122872 |
Chachoua, I., Pecquet, C., El-Khoury, M., Nivarthi, H., Albu, R.-I., Marty, C., Gryshkova, V., Defour, J.-P., VERTENOEIL, G., Ngo, A., Koay, A., Raslova, H., Courtoy, P. J., Choong, M. L., Plo, I., Vainchenker, W., Kralovics, R., & Constantinescu, S. N. (2016). Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants. Blood, 127 (10), 1325-35. doi:10.1182/blood-2015-11-681932 |
Mosca, M.* , VERTENOEIL, G.* , Toppaldoddi, K. R., Plo, I., & Vainchenker, W. (2016). Aspects biologiques de la voie JAK/STAT dans les néoplasmes myéloprolifératifs classiques négatifs pour BCR-ABL. Bulletin du Cancer, 103 (6 Suppl 1), 16-28. doi:10.1016/S0007-4551(16)30142-4 * These authors have contributed equally to this work. |
VERTENOEIL, G., SERVAIS, S., & Beguin, Y. (2012). Comment j'explore... une fièvre d'origine indéterminée chez le patient adulte ? Revue Médicale de Liège, 67 (7-8), 391-397. |
Malaise, O., Lambert, F., Damsin, T., GESTER, F., PAQUOT, C., & VERTENOEIL, G. (02 February 2025). Syndrome de VEXAS [Paper presentation]. GLEM du service de rhumatologie du CHU de Liège. |
Malaise, O., Von Frenckell, C., Mina, M., Rinkin, C., DAMSIN, T., GESTER, F., El Moussaoui, M., PAQUOT, C., Lambert, F., De Voeght, A., Ribbens, C., & VERTENOEIL, G. (18 September 2024). VEXAS syndrome: at the intersection between rheumatology and hematology. But have we thought about inviting the dermatologist? [Poster presentation]. Belgian Congress of Rheumatology 2024. |
Lombardo, G., HAFRAOUI, K., Beguin, Y., & VERTENOEIL, G. (February 2024). Comment j’explore … une polyglobulie. Revue Médicale de Liège, 79 (2), 110 - 115. |